Hepion Pharmaceuticals, Inc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINES-8Hepion Pharmaceuticals, Inc.CTRVP4d

   Hepion Pharmaceuticals files S-8 form

   • Filed on 2026-10-14
   • Registers 10,000,000 additional shares
   • Related to 2023 Omnibus Equity Incentive Plan
2. ROUTINE8-KHepion Pharmaceuticals, Inc.CTRVPOct 9

   Hepion Pharmaceuticals acquires GLS

   • Acquired Gravitas Life Sciences for $2M cash and 25M shares
   • GLS becomes wholly owned subsidiary
   • Transaction involved related parties
3. ROUTINE8-KHepion Pharmaceuticals, Inc.CTRVPOct 2

   Hepion Pharmaceuticals increases stock shares

   • Filed Certificate of Amendment on Oct 1, 2026
   • Authorized shares increased to 750,000,000
   • Effective upon filing with Delaware Secretary of State
4. ROUTINE4Hepion Pharmaceuticals, Inc.CTRVPOct 2

   Fisher Danina bought shares of HEPA

   • Purchased 200,000 common shares at $0.05
   • Purchased 200,000 warrants at $0.06
   • Date of transaction: 09/29/2026

   Danina Fisher

5. ROUTINE8-KHepion Pharmaceuticals, Inc.CTRVPSep 28

   Current report

6. ROUTINE3Hepion Pharmaceuticals, Inc.CTRVPSep 16

   KI Holdings, Ltd., new insider at CTRVP

   KI Holdings, Ltd., reporting

7. NOTABLESCHEDULE 13D/AHepion Pharmaceuticals, Inc.CTRVPSep 16

   Ownership stake disclosure by KI Holdings, Ltd. (amended)

   KI Holdings, Ltd., filed by

8. ROUTINESCHEDULE 13GHepion Pharmaceuticals, Inc.CTRVPSep 15

   Ownership stake disclosure by Kenneth Rickel

   Kenneth Rickel, filed by

9. ROUTINE4Hepion Pharmaceuticals, Inc.CTRVPSep 14

   Vincent S LoPriore, insider filing for CTRVP

   Vincent S LoPriore, reporting

10. ROUTINEDEF 14CHepion Pharmaceuticals, Inc.CTRVPSep 10

    DEF 14C filing

11. ROUTINE4Hepion Pharmaceuticals, Inc.CTRVPSep 10

    Michael J. Purcell, insider filing for CTRVP

    Michael J. Purcell, reporting

12. ROUTINE8-KHepion Pharmaceuticals, Inc.CTRVPSep 8

    Current report

13. ROUTINE8-KHepion Pharmaceuticals, Inc.CTRVPAug 27

    Current report

14. ROUTINE4Hepion Pharmaceuticals, Inc.CTRVPAug 21

    7 insider filings

    Gary S. Stetz, insider filing for CTRVP

    Show all 7

    • 4Insider filing for CTRVPAug 21
    • 4Insider filing for CTRVPAug 21
    • 4Insider filing for CTRVPAug 21
    • 4Insider filing for CTRVPAug 21
    • 4Insider filing for CTRVPAug 21
    • 4Insider filing for CTRVPAug 21
    • 4Insider filing for CTRVPAug 21

    Gary S. Stetz, reporting

15. ROUTINE3Hepion Pharmaceuticals, Inc.CTRVPAug 21

    James Gordon Liddy, new insider at CTRVP

    James Gordon Liddy, reporting

16. ROUTINE8-KHepion Pharmaceuticals, Inc.CTRVPAug 20

    Current report

17. NOTABLESCHEDULE 13D/AHepion Pharmaceuticals, Inc.CTRVPAug 20

    Ownership stake disclosure by Vincent S LoPriore (amended)

    Vincent S LoPriore, filed by

18. NOTABLESCHEDULE 13DHepion Pharmaceuticals, Inc.CTRVPAug 20

    Ownership stake disclosure by Gary S. Stetz

    Gary S. Stetz, filed by

19. NOTABLESCHEDULE 13DHepion Pharmaceuticals, Inc.CTRVPAug 20

    Ownership stake disclosure by Sireesh Appajosyula

    Sireesh Appajosyula, filed by

20. NOTABLE10-QHepion Pharmaceuticals, Inc.CTRVPAug 13

    Quarterly report

21. ROUTINE4Hepion Pharmaceuticals, Inc.CTRVPAug 12

    5 insider filings

    Gary S. Stetz II, insider filing for CTRVP

    Show all 5

    • 4Insider filing for CTRVPAug 12
    • 4Insider filing for CTRVPAug 12
    • 4Insider filing for CTRVPAug 12
    • 4Insider filing for CTRVPAug 12
    • 4Insider filing for CTRVPAug 12

    Gary S. Stetz II, reporting

22. ROUTINE3Hepion Pharmaceuticals, Inc.CTRVPAug 7

    Black Global 5 LLC, new insider at CTRVP

    Black Global 5 LLC, reporting

23. ROUTINES-8Hepion Pharmaceuticals, Inc.CTRVPAug 7

    Employee stock plan registration

24. NOTABLESCHEDULE 13DHepion Pharmaceuticals, Inc.CTRVPAug 7

    Ownership stake disclosure by Black Global 5 LLC

    Black Global 5 LLC, filed by

25. ROUTINEDHepion Pharmaceuticals, Inc.CTRVPAug 5

    Private placement notice

26. ROUTINE8-KHepion Pharmaceuticals, Inc.CTRVPAug 4

    Current report

27. ROUTINE3Hepion Pharmaceuticals, Inc.CTRVPJul 10

    Gary S. Stetz II, new insider at CTRVP

    Gary S. Stetz II, reporting

28. ROUTINE3Hepion Pharmaceuticals, Inc.CTRVPJul 8

    Danina Fisher, new insider at CTRVP

    Danina Fisher, reporting

29. ROUTINE8-KHepion Pharmaceuticals, Inc.CTRVPJul 2

    Current report

30. ROUTINE8-KHepion Pharmaceuticals, Inc.CTRVPJun 17

    Current report

31. ROUTINE3Hepion Pharmaceuticals, Inc.CTRVPMay 26

    Chase LoPriore, new insider at CTRVP

    Chase LoPriore, reporting

32. NOTABLE10-QHepion Pharmaceuticals, Inc.CTRVPMay 14

    Quarterly report

33. NOTABLESCHEDULE 13DHepion Pharmaceuticals, Inc.CTRVPMay 1

    Ownership stake disclosure by Vincent S LoPriore

    Vincent S LoPriore, filed by

34. ROUTINEARSHepion Pharmaceuticals, Inc.CTRVPApr 28

    Annual report to shareholders

35. ROUTINEDEFA14AHepion Pharmaceuticals, Inc.CTRVPApr 28

    Additional proxy materials

36. ROUTINEDEF 14AHepion Pharmaceuticals, Inc.CTRVPApr 28

    Proxy statement

37. ROUTINE4Hepion Pharmaceuticals, Inc.CTRVPApr 27

    Michael J. Purcell, insider filing for CTRVP

    Michael J. Purcell, reporting

38. ROUTINE4Hepion Pharmaceuticals, Inc.CTRVPApr 27

    3 insider filings

    Vincent S LoPriore, insider filing for CTRVP

    Show all 3

    • 4Insider filing for CTRVPApr 27
    • 4Insider filing for CTRVPApr 27
    • 4Insider filing for CTRVPApr 27

    Vincent S LoPriore, reporting

Older filings on EDGAR